DOI: https://doi.org/10.55522/jmpas.V13I5.6617
VOLUME 13 – ISSUE 5, SEPTEMBER - OCTOBER 2024
Subashini P*, Ramesh S
Department of Pharmaceutics, Sri Ramachandra Faculty of Pharmacy, Chennai, Tamil Nadu, India
Refer this article
Subashini P, Ramesh S, 2024. Strategic insights: Unveiling the potential of Pharmaceutical exports from India to Regulated markets. Journal of medical pharmaceutical and allied sciences, V 13 - I 5, Pages - 6783 – 6790. Doi: https://doi.org/10.55522/jmpas.V13I5.6617.
ABSTRACT
India is a major exporter of medicinal products in the world. India's pharmaceutical sector has grown significantly to contribute largely to the GDP of the nation because of its rapidly expanding economy and abundance of highly skilled labor. However, exporting pharmaceuticals to markets that are subject to regulations can be a difficult procedure that requires a lot of paperwork. This all-inclusive handbook will assist in navigating the documentation and export regulatory requirements for pharmaceutical exports from India to regulated markets. It also provides export projections for the future, enabling exporters to adapt their export strategy. This handbook will give you the knowledge needed to be successful in the pharmaceutical export business, regardless of whether an experienced exporter or a recent entry into the market. A study on Indian Pharmaceutical Exporter together with future forecasts and SWOT Analysis of Indian Pharmaceutical manufacturers.
Keywords:
Regulated & semi-regulated pharmaceutical market, Future Export prediction,and documentation, SWOT Analysis (Strength, Weakness, Opportunity, and Threats).